Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer
Clinical trial NCT02722538 · COMPLETED
Trial details
- NCT number
- NCT02722538
- Sponsor
- Taris Biomedical LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-31
- Primary completion
- 2019-05-02
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.